Your browser is no longer supported. Please, upgrade your browser.
FLGT Fulgent Genetics, Inc. monthly Stock Chart
FLGT [NASD]
Fulgent Genetics, Inc.
Index- P/E345.44 EPS (ttm)0.11 Insider Own7.30% Shs Outstand21.75M Perf Week14.51%
Market Cap803.35M Forward P/E18.85 EPS next Y2.09 Insider Trans-9.52% Shs Float11.93M Perf Month-12.10%
Income2.50M PEG7.77 EPS next Q0.53 Inst Own30.40% Short Float9.91% Perf Quarter143.24%
Sales43.80M P/S18.34 EPS this Y93.00% Inst Trans4.34% Short Ratio1.28 Perf Half Y229.82%
Book/sh4.00 P/B9.85 EPS next Y75.25% ROA3.00% Target Price17.33 Perf Year256.38%
Cash/sh1.02 P/C38.44 EPS next 5Y44.45% ROE3.30% 52W Range6.70 - 52.47 Perf YTD205.27%
Dividend- P/FCF- EPS past 5Y17.30% ROI-0.60% 52W High-24.95% Beta1.84
Dividend %- Quick Ratio6.30 Sales past 5Y91.00% Gross Margin55.90% 52W Low487.76% ATR3.65
Employees139 Current Ratio6.30 Sales Q/Q106.00% Oper. Margin4.30% RSI (14)61.85 Volatility9.02% 10.64%
OptionableYes Debt/Eq0.00 EPS Q/Q732.80% Profit Margin5.80% Rel Volume1.28 Prev Close39.52
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout0.00% Avg Volume922.02K Price39.38
Recom2.00 SMA2022.73% SMA5018.85% SMA200103.32% Volume1,183,160 Change-0.35%
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-19Upgrade Piper Jaffray Neutral → Overweight
Mar-01-18Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Raymond James Outperform → Mkt Perform
Sep-22-20 07:59AM  
Sep-21-20 06:41PM  
Sep-20-20 10:18AM  
Sep-15-20 08:00AM  
Sep-09-20 08:00AM  
Sep-04-20 10:29AM  
08:00AM  
Sep-03-20 12:20PM  
12:08PM  
07:55AM  
06:00AM  
Sep-02-20 09:25PM  
04:05PM  
Sep-01-20 09:42AM  
Aug-27-20 04:27PM  
12:23PM  
Aug-21-20 01:28PM  
Aug-20-20 09:51AM  
Aug-17-20 07:00AM  
Aug-05-20 07:26AM  
06:01AM  
Aug-04-20 04:05PM  
Jul-14-20 08:00AM  
Jun-25-20 12:28PM  
Jun-17-20 10:32AM  
09:49AM  
03:05AM  
Jun-16-20 04:05PM  
May-22-20 02:32AM  
May-18-20 06:00AM  
May-05-20 11:00AM  
May-04-20 04:05PM  
Apr-16-20 08:17AM  
Apr-09-20 08:01AM  
08:00AM  
Mar-27-20 03:22AM  
Mar-17-20 08:00AM  
Mar-10-20 04:23PM  
04:05PM  
02:30PM  
08:00AM  
Mar-02-20 09:44AM  
Feb-24-20 08:28AM  
Feb-20-20 08:00AM  
Feb-07-20 07:54AM  
Feb-06-20 03:34PM  
11:23AM  
11:17AM  
Jan-24-20 06:51AM  
Jan-20-20 11:30AM  
Jan-03-20 08:22AM  
Jan-02-20 10:19AM  
Dec-20-19 06:38PM  
11:33AM  
Dec-19-19 11:09AM  
10:08AM  
Dec-02-19 05:00AM  
Nov-25-19 08:00AM  
Nov-19-19 09:31AM  
Nov-18-19 08:06AM  
Nov-13-19 11:15PM  
04:01PM  
06:13AM  
Nov-12-19 03:05PM  
10:00AM  
Nov-11-19 10:16AM  
Nov-08-19 10:20AM  
Nov-04-19 04:05PM  
Oct-15-19 08:00AM  
Oct-14-19 08:06AM  
Sep-18-19 08:20AM  
Sep-16-19 08:00AM  
Aug-20-19 09:38AM  
Aug-19-19 09:32AM  
Aug-12-19 02:27PM  
Aug-05-19 04:05PM  
02:30PM  
08:00AM  
Aug-01-19 04:15PM  
Jul-29-19 10:34AM  
Jul-22-19 08:00AM  
Jul-16-19 09:15AM  
Jul-15-19 11:43AM  
Jun-07-19 03:41PM  
May-14-19 11:54PM  
May-07-19 04:05PM  
Apr-26-19 02:25PM  
Apr-18-19 08:00AM  
Mar-22-19 04:48PM  
Mar-08-19 12:59PM  
Feb-28-19 04:05PM  
Feb-21-19 10:31AM  
Feb-20-19 10:31AM  
08:00AM  
Feb-06-19 12:44PM  
Jan-03-19 08:00AM  
Dec-03-18 10:17PM  
Nov-27-18 04:05PM  
Nov-23-18 03:53AM  
Nov-06-18 04:05PM  
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIM PAULCFO and TreasurerSep 02Sale28.3242512,035335,899Sep 03 08:45 PM
Xie JianChief Operating OfficerAug 28Sale30.8244113,591601,295Sep 23 07:35 PM
KIM PAULCFO and TreasurerAug 19Sale44.1625,4071,122,039335,774Aug 19 09:14 PM
BOLGER JOHN CDirectorAug 17Option Exercise12.312,63132,3935,927Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 17Sale41.65111,2364,633,097361,181Aug 19 09:14 PM
Gao HanlinChief Scientific OfficerAug 17Sale41.111,30853,7721,281,351Aug 19 09:11 PM
BOLGER JOHN CDirectorAug 17Sale40.873,914159,9672,013Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 11Sale42.061,39658,712472,417Aug 12 04:28 PM
Xie JianChief Operating OfficerAug 03Sale27.861,97655,055601,736Aug 05 08:57 PM
KIM PAULCFO and TreasurerJun 02Sale18.064257,674433,813Jun 03 05:14 PM
BOLGER JOHN CDirectorMay 22Option Exercise2.115,13110,81211,973May 27 07:48 PM
BOLGER JOHN CDirectorMay 22Sale15.368,677133,2883,296May 27 07:48 PM
KIM PAULCFO and TreasurerMay 12Sale16.311,42123,176434,238May 13 07:13 PM